Parthenolide (PTL) is an accepted inhibitor extracted from Tanacetum balsamita that can be inhibited by the NF- κB/TGF-β/Smad signaling axis, inhibits inflammation and reduces PF (Zhang et al., 2022). The gene discussed is TGFB1; the disease is pemphigus foliaceus.